KYMR
KYMR
NASDAQ · Biotechnology

Kymera Therapeutics Inc

$74.42
-2.54 (-3.30%)
As of Mar 24, 9:50 PM ET ·
Analyst Consensus
Strong Buy
29
Analysts
High
Coverage
Buy 27 93%
Hold 2 7%
Sell 0 0%
Price Target
Analyst Price Target -58.3% upside
Low Target $20.33
Average Target $31.03
High Target $33.62
Current Price $74.42
Current
$74.42
Target
$31.03
$20.33 $31.03 avg $33.62
Scenario Analysis
Bear Case
$20.33
-72.7%
Low target
Base Case
$31.03
-58.3%
Avg target
Bull Case
$33.62
+-54.8%
High target
Risk/Reward
0.8x
Unfavorable
Price in Context
52-Week High
$103.00
-27.7% from high
52-Week Low
$19.45
+282.7% from low
50-Day SMA
$78.66
-5.4% vs SMA
200-Day SMA
$56.03
+32.8% vs SMA
RSI (14)
77.3
Overbought
Target vs 52W High
$31.03
-69.9% vs high
Peer Consensus — Biotechnology
Stock Consensus Analysts Buy % Target Upside
ABBV
Abbvie Inc
Buy 39 69% $257.58 +25.5%
AMGN
Amgen Inc
Hold 42 50% $190.87 -45.2%
GILD
Gilead Sciences Inc
Strong Buy 37 81% $362.68 +162.6%
VRTX
Vertex Pharmaceuticals Inc
Strong Buy 39 79% $438.34 -2.3%
REGN
Regeneron Pharmaceuticals
Strong Buy 36 75% $76.80 -89.6%
ALNY
Alnylam Pharmaceuticals Inc
Strong Buy 36 78% $102.31 -66.8%
INSM
Insmed Inc
Strong Buy 26 92% $143.40 +3.1%
NTRA
Natera Inc
Strong Buy 27 89% $142.91 -26.5%